Medication info
Tenelpomine Extended-release Tablet 10/750 mg

Tenelpomine Extended-release Tablet 10/750 mg

Prescription medicationTabletOral
Ingredient · strength
Teneligliptin Hydrochloride Hydrate›13mg / 1 tabletMetformin Hydrochloride›750mg / 1 tablet
Manufacturer / importer
Daehan New Pharm Co., Ltd.
Appearance
Yellow oval-shaped extended-release film-coated tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 202201318 · Approved 2022.04.04 · Insurance code 669908170

Summary

Main use
Improvement of glycemic control in patients with type 2 diabetes
Who takes it
Adults
Adult dose
The dose of this medicine should be determined based on each patient's current treatment, efficacy, and tolerability. This medicine is generally administered once daily with the evening meal. The dose should be titrated gradually to reduce gastrointestinal adverse effects associated with metformin. Take one 20/1000mg extended-release tablet once daily. Patients taking the 10/750mg or 10/500mg extended-release tablets should take 2 tablets together once daily. For patients whose blood glucose is not adequately controlled with metformin monotherapy, the initial dose of this medicine should provide teneligliptin 20 mg once daily and the patient's current metformin dose. For patients switching from combination therapy with teneligliptin and metformin to this medicine, treatment may be initiated at the current doses of teneligliptin and metformin. When switching from immediate-release to extended-release metformin, blood glucose control should be monitored closely and the dose adjusted appropriately. When coadministered with a sulfonylurea, a reduction in the sulfonylurea dose may be considered to reduce the risk of hypoglycemia. The maximum recommended daily dose is teneligliptin 20mg and extended-release metformin 2000mg. The safety and efficacy of this medicine have not been specifically evaluated in patients switching to it from another antihyperglycemic agent. Since such a change may cause changes in blood glucose control, any change in treatment for patients with type 2 diabetes should be made under careful monitoring. To maintain its extended-release properties, swallow this medicine whole; do not split, crush, grind, or chew it.

Ingredients

Manufacturer
Daehan New Pharm Co., Ltd.

Efficacy & effects

Improvement of glycemic control in patients with type 2 diabetes

View approved original text

This medication is an effective treatment to assist in the dietary control and exercise regimen for patients with type 2 diabetes to help control blood sugar levels. It is particularly suitable for patients who require combination therapy with teneligliptin and metformin, and helps in the stable management of blood sugar levels. Consistent use improves blood sugar control, significantly aiding in diabetes management.

How to take

Adult dose

The dose of this medicine should be determined based on each patient's current treatment, efficacy, and tolerability. This medicine is generally administered once daily with the evening meal. The dose should be titrated gradually to reduce gastrointestinal adverse effects associated with metformin. Take one 20/1000mg extended-release tablet once daily. Patients taking the 10/750mg or 10/500mg extended-release tablets should take 2 tablets together once daily. For patients whose blood glucose is not adequately controlled with metformin monotherapy, the initial dose of this medicine should provide teneligliptin 20 mg once daily and the patient's current metformin dose. For patients switching from combination therapy with teneligliptin and metformin to this medicine, treatment may be initiated at the current doses of teneligliptin and metformin. When switching from immediate-release to extended-release metformin, blood glucose control should be monitored closely and the dose adjusted appropriately. When coadministered with a sulfonylurea, a reduction in the sulfonylurea dose may be considered to reduce the risk of hypoglycemia. The maximum recommended daily dose is teneligliptin 20mg and extended-release metformin 2000mg. The safety and efficacy of this medicine have not been specifically evaluated in patients switching to it from another antihyperglycemic agent. Since such a change may cause changes in blood glucose control, any change in treatment for patients with type 2 diabetes should be made under careful monitoring. To maintain its extended-release properties, swallow this medicine whole; do not split, crush, grind, or chew it.

Precautions

This medication is used for treating diabetes and helps in controlling blood sugar levels. However, it is safer not to use this medication in patients with impaired kidney function or heart issues. Especially, it should not be taken by patients with moderate to severe kidney impairment or those with acute heart diseases, congestive heart failure, or severe liver dysfunction. When undergoing examinations that use radiologic contrast agents, this medication should be discontinued 48 hours prior to the exam and resumed only after confirming normal kidney function post-examination. It is also advisable for pregnant women or those who may become pregnant, and severely malnourished or patients with severe infections to avoid this medication. This medication can increase the risk of hypoglycemia when taken with other diabetes treatments, so it is important to be well aware of hypoglycemic symptoms and management. While taking this medication, if unusual symptoms such as dizziness, abdominal pain, vomiting, constipation, shortness of breath, skin rash, or severe joint pain occur, consult a physician immediately. Additionally, this medication can rarely cause a serious metabolic condition known as lactic acidosis, so if symptoms such as weakness, difficulty in breathing, or abdominal pain appear, go to the hospital immediately. Regular checking of kidney and liver function is important to reduce the risk of drug accumulation and side effects. Alcohol consumption may increase the risk of side effects from this medication, so it is advisable to avoid drinking while on this medication. Elderly patients often experience reduced kidney function, thus requiring dosage adjustment and regular check-ups. During treatment with this medication, blistering skin diseases or severe joint pain may occur, so report any such symptoms to a physician immediately. In case of overdose, immediate treatment is necessary, and the drug can be removed through blood dialysis. Finally, keep this medication out of the reach of children and do not transfer it to other containers.

Side effects

Severe lactic acidosis, severe hypoglycemia, hypoglycemia, constipation, bowel obstruction, liver dysfunction, interstitial pneumonia, bullous pemphigoid, acute pancreatitis, dizziness, abdominal distension, abdominal discomfort, nausea, abdominal pain, flatulence, stomatitis, gastric polyps, colonic polyps, duodenal ulcers, gastroesophageal reflux disease, diarrhea, loss of appetite, elevated amylase, elevated lipase, increased AST (GOT), increased ALT (GPT), increased GGT, increased ALP, proteinuria, ketonuria, potential hematuria, eczema, rash, itching, allergic dermatitis, arthralgia, elevated CK (CPK), increased serum potassium levels, fatigue, allergic rhinitis, increased serum uric acid, peripheral edema, herpes zoster, limb pain, epigastric pain, gastritis, upper respiratory tract infection, tremors, headache, asthenia, hunger, fatigue, facial edema, dyspepsia, nausea, viral upper respiratory tract infection, rhinitis, cold sweat, diabetic retinopathy, reduced vision, cough, pulmonary congestion, dyspnea, drug overdose, benign prostatic hyperplasia, headache, diarrhea, chronic gastritis, irritable bowel syndrome, fatigue, cerebral infarction, hyperglycemia, liver biopsy, decreased neutrophil count, abnormal blood sugar, increased blood sugar, increased blood pressure, hepatic coma, lumbar spinal canal stenosis, spinal intervertebral disc protrusion, intervertebral disc disorder, spinal ligament ossification, spinal foraminal stenosis, rotator cuff syndrome, bladder tumor, ureteral calculi, urinary stones, coronary artery disease, unstable angina, gastroesophageal reflux disease, gastric polyps, gastritis, bile duct obstruction, chronic cholecystitis, soft tissue infection, pneumonia, cataract, depression, iliac artery stenosis, vertigo, benign prostatic hyperplasia, knee surgery, dizziness, diabetic neuropathy, sensory abnormalities, muscle weakness, low back pain, limb pain, lumbar spinal canal stenosis, tendinitis, cervical pain, bone pain, osteoarthritis, osteoporosis, muscle spasms, foot deformities, hypertrophic osteoarthropathy, bursitis, spinal osteoarthritis, intervertebral disc protrusion, intervertebral disc disorder, spinal ligament ossification, spinal foraminal stenosis, postmenopausal osteoporosis, rotator cuff syndrome, gastritis, vomiting, chronic gastritis, epigastric pain, dysentery, gastrointestinal motility disorder, gastrointestinal motility impairment, enteritis, toothache, anal rectal discomfort, acquired mixed hyperlipidemia, hypertriglyceridemia, vitamin D deficiency, abnormal weight gain, essential hypertension, orthostatic hypotension, white coat hypertension, bleeding, cough, insomnia, urticaria, hepatic coma, sensory impairment, sensory reduction, tension headache, peripheral neuropathy, facial paralysis, sciatica, position-related dizziness, headache, arthralgia, herpes zoster, upper respiratory tract infection, gastritis, dyspepsia, increased blood sugar, dyspnea, expiratory dyspnea, atelectasis, nasal bleeding, chest discomfort, fever, chills, generalized edema, injection site inflammation, fatigue, chest pain, ureteral calculi, dysuria, renal cysts, nocturia, depression, anxiety disorder due to general medical condition, ovarian cysts, vulvar pruritus, menopausal symptoms, toxic hepatitis, non-alcoholic fatty liver disease, alcoholic liver disease, eyelid injury, ligament sprain, lip injury, contusion, pressure sore ulcers, glaucoma, blurred vision, age-related macular degeneration, hyperthyroidism, hyperparathyroidism, coronary artery disease, unstable angina, angina, otalgia, vertigo, iron deficiency anemia, food allergy

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air exposure, at room temperature between 1 to 30 degrees. Proper storage maintains the medication's efficacy and prevents degradation.

Appearance and packaging

Appearance

Yellow oval-shaped extended-release film-coated tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.